AVBCC Value-Based Voices – Détails, épisodes et analyse

Détails du podcast

Informations techniques et générales issues du flux RSS du podcast.

AVBCC Value-Based Voices

Rachael

Business & Entrepreneuriat

Fréquence : 1 épisode/15j. Total Éps: 13

The Association for Value-Based Cancer Care’s (AVBCC) podcast series addresses the ever-evolving

landscape of value related to cancer care in the United States. Our goal is to foster informed dialogue, promote transparency, and empower all players to navigate the rapidly changing landscape of cancer care with clarity and confidence.

Lire plusRéduire

Site

RSS

Apple

Classements récents

Dernières positions dans les classements Apple Podcasts et Spotify.

Apple Podcasts

🇺🇸 États-Unis - nonProfit
15/08/2026
#73
🇺🇸 États-Unis - nonProfit
13/08/2026
#87
🇺🇸 États-Unis - nonProfit
26/07/2026
#100
🇺🇸 États-Unis - nonProfit
12/05/2026
#66
🇺🇸 États-Unis - nonProfit
11/05/2026
#86
🇺🇸 États-Unis - nonProfit
10/05/2026
#61
🇺🇸 États-Unis - nonProfit
09/05/2026
#38
🇺🇸 États-Unis - nonProfit
08/05/2026
#30
🇺🇸 États-Unis - nonProfit
07/05/2026
#24
🇺🇸 États-Unis - nonProfit
06/05/2026
#66

Spotify

Aucun classement récent disponible

Liens partagés entre épisodes et podcasts

Liens présents dans les descriptions d'épisodes et autres podcasts les utilisant également.

https://www.linkedin.com/company/avbcc/?viewAsMember=true
13 partages
https://www.linkedin.com/in/jayson-slotnik-3932305/
6 partages
https://www.linkedin.com/in/steve-usdin-88aa872/
4 partages

https://avbcc.org/podcast/
13 partages
https://reidstrategic.com/
2 partages
https://communityoncology.org/
2 partages

https://youtu.be/ESDv91P_SHU?si=I3hpsri0ooM5Jct0
1 partage

Qualité et score du flux RSS

Évaluation technique de la qualité et de la structure du flux RSS.

Qualité du flux RSS

À améliorer

Score global : 42%

Historique des publications

Répartition mensuelle des publications d'épisodes au fil des années.

Year

Derniers épisodes publiés

Liste des épisodes récents, avec titres, durées et descriptions.

Insights from JP Morgan 2026 with Liz Fowler, PhD, JD

Saison 1 · Épisode 1

dimanche 8 février 2026 • Durée 25:20

Commercial health plans may have been missing from J.P. Morgan 2026, but government had a big presence! Value-Based Voices host Burt Zweigenhaft, PhD, and nationally recognized health policy expert Liz Fowler, PhD, JD, share their observations from this year’s meeting and key insights around most-favored nation prescription drug pricing, 340B, PBMs, Medicare site neutrality, AI, and of course value-based care.

Contact Value-Based Voices

- Follow AVBCC on LinkedIn

- View our podcast lineup

- Contact us at info@avbcc.org

Thanks for listening!

Lire plusRéduire

More Insights from JP Morgan 2026 with Jeff Berkowitz, JD

Saison 1 · Épisode 2

dimanche 8 février 2026 • Durée 39:07

Where was the drama at JP Morgan this year? Host Burt Zweigenhaft, PhD, and seasoned healthcare executive Jeff Berkowitz, JD, debate why the 2026 meeting seemed to be missing its normal electricity. They also share their thoughts around challenges with direct-to-patient models, most-favored-nation and its impact on product launch and pricing both in the US and Europe, and how AI may or may not be the key to finally achieving value-based outcomes.

Contact Value-Based Voices

- Follow AVBCC on LinkedIn

- View our podcast lineup

- Contact us at info@avbcc.org

Thanks for listening!

Lire plusRéduire

AI Revolution: Breaking Pharmacy Chains with Harry Travis, BS Pharm, MBA, and Ira Klein, MD, MBA, FACP

Saison 1 · Épisode 4

mardi 17 mars 2026 • Durée 22:28

There are countless opportunities hidden in the data-driven tasks pharmacists do every day, and AI is ready to unlock them. But what happens when automation dramatically increases productivity in pharmacy, and how do regulations, workforce, and patient care evolve in tandem?

In this latest episode of AVBCC's Value-Based Voices, join Ira Klein , MD, MBA, FACP, VP Medical Affairs, Payer Relations, Tempus Labs, and AI innovator Harry Travis, BS Pharm, MBA, President, The Travis Group, LLC, as they explore how AI could revolutionize pharmacy practice by speeding up prior authorizations, freeing pharmacists from administrative burdens, and expanding their roles in patient care. You’ll discover how AI can automate endless data questions, streamline workflows, and help pharmacists work at the top of their license—shifting from manual tasks to meaningful, patient-centered interactions.

We'll break down:

- Why pharmacy is a perfect testbed for AI’s potential to enhance precision and efficiency

- The regulatory landscape across states and the role of federal organizations in creating a unified framework

- How AI can enable pharmacists to deliver advanced clinical services like prescribing and primary care

- The implications for the pharmacy workforce, workforce reallocation, and upskilling necessary for these shifts

- The ripple effects across payers, PBMs, and healthcare systems seeking faster, smarter decision-making

This isn’t just about technology, it's about reimagining healthcare delivery and empowering professionals to provide better patient outcomes. Health professionals and healthcare leaders: if you’re ready to harness AI to transform pharmacy practice, avoid workforce disruption, and improve access, this episode is essential listening.

Resources

National Association of Boards of Pharmacy - https://nabp.pharmacy/

AI in Healthcare - McKinsey Report - https://www.mckinsey.com/industries/healthcare-systems-and-services/our-insights/ai-in-healthcare

Consolidation Versus Independence in Cancer Care

Saison 1 · Épisode 3

mardi 24 février 2026 • Durée 25:10

Is consolidation in cancer care truly the best path forward, or does independence offer greater benefits?

In this episode of Value-Based Voices Sarah Alwardt, PhD, President, Avalere Health, and Jeff Patton, MD, CEO, OneOncology, discuss the nuances of consolidation versus independence in cancer care, the impact of policy and capital access, and the future of value-based oncology. Gain insights into sustainable models, data utilization, and patient-centered strategies.

Contact Value-Based Voices

- Follow AVBCC on LinkedIn

- View our podcast lineup

- Contact us at info@avbcc.org

Thanks for listening!

Lire plusRéduire

Navigating Value and Policy in U.S. Cancer Care and Pharma Pricing

Saison 1 · Épisode 6

jeudi 30 avril 2026 • Durée 34:48

International reference pricing could drastically reshape drug costs in the U.S. and threaten domestic innovation. In this latest episode of AVBCC’s Value-Based Voices, join Jayson Slotnik, JD, MPH, Partner, Health Policy Strategies, Inc., and Member of the AVBCC Board of Directors, and healthcare policy strategist Brian Reid, MS, Founder of Reid Strategic, as they unpack the complex debate over the proposed international MFN models like Globe, Guard, and Generous — and whether they will do more harm than good for U.S. patients and providers.

We break down key insights that every healthcare leader and policymaker must understand including:

· The likelihood of lawsuits derailing MFN policies

· Political winds shifting in favor of international price controls

· How China’s emerging role could reshape global drug markets

Reid offers a clear framework on the potential legal, economic, and geopolitical impacts of this battle, plus practical predictions about the next steps for PBMs and 340B.

This episode is essential listening for executives, clinicians, and advocates eager to grasp how these international pricing debates could dictate the cost and availability of cancer drugs and other critical medicines in our lifetime

Tune in now to navigate the murky waters of international reference pricing and stay ahead of the policy curve that could dramatically alter cancer care in America.

Resources & Links:

Cost Curve Newsletter
Brian Reid's Website
Connect with Brian Reid:
LinkedIn
Connect with Jayson Slotnik:
LinkedIn

Contact Value-Based Voices

Most Favored Nation and What's Next

mardi 14 avril 2026 • Durée 33:49

Most companies, and even policymakers, are betting big on importing international drug prices — but what does that really mean for cancer care in America?

In this episode of Value-Based Voices, Jayson Slotnik, JD, MPH, Partner, Health Policy Strategies, Inc., dives into the evolving landscape of drug pricing reforms, unlocking why policies like the Most Favored Nation (MFN) and the Global Benchmark could reshape how medicines reach patients, providers, and payers. You’ll discover how these models aim to lower drug costs by benchmarking against prices from other countries, and why that sparks fierce debate about innovation, access, and the future of American healthcare. Nick Ferreyros, Managing Director, Policy, Advocacy, and Communications, Community Oncology Alliance (COA), and Tim Dube, MPH, Senior Vice President, Policy & Regulatory Affairs, PCMA, unpack the complexities of the Guard and Globe models, revealing how they impact community oncology practices, Medicare, and even the pharmaceutical industry. They break down the technicalities of rebate mechanisms, international price comparisons, and the legal road ahead — all with a sharp focus on what it means for patients facing cancer.

This episode explores critical questions: Will these policies truly deliver lower costs without compromising quality? Are they just the beginning of a long legal and political fight? And how might they reshape the innovation landscape in cancer treatment? With perspectives from advocates and industry insiders, you'll see why this isn’t just about policy — it’s about the future of patient care, physician practice, and our healthcare system at large. If you’re navigating the high-stakes world of cancer care reform, this conversation is essential.

Resources & Links:

• Community Oncology Alliance (COA)

• PCMA — Pharmaceutical Care Management Association

Connect with the Guests:

• Jayson Slotnik

Reflections on the NCCN

Saison 1 · Épisode 10

mardi 30 juin 2026 • Durée 24:02

In this episode of Value-Based Voices, we delve into the mission and inner workings of the NCCN, a cornerstone organization shaping cancer treatment standards in the U.S. and beyond. We're joined by Bill McGivney, PhD, Principal, McGivney Global Advisors, and Former CEO, NCCN; and host Nicolas Ferreyros, Managing Director, Policy, Advocacy, and Communications, Community Oncology Alliance.

Hear expert insights on how guidelines, payer decisions, and evolving technologies influence patient access and outcomes as well as some of Bill's own thoughts on the NCCN and his time at its helm.

Resources & Links:

Connect with Our Guests:

Contact Value-Based Voices

- Follow AVBCC on LinkedIn

- View our podcast lineup

- Contact us at info@avbcc.org

Thanks for listening!

Lire plus

Advancing Cancer Research and Innovation through Collaboration at GCRIS 2026

mardi 16 juin 2026 • Durée 33:22

We're taking a deep dive into the upcoming Global Cancer Research and Innovation Symposium (GCRIS) in this latest episode of Value-Based Voices.

Join GCRIS Scientific Co-chairs Stan Skrzypczak, MS, MBA, Managing Partner, 5 Prime Life Science Consulting, and Nick Sarlis, MD, PhD, FACP, Chief Medical Officer, Cleara Biotech, as they talk with GCRIS Co-chair Matt Vossler, Managing Director, DSG Global, about the groundbreaking science, innovative drug development, and collaborative ecosystems that are reshaping oncology.

Hear about:
- the rise of "biotech 2.0"
- the complexity of bringing new therapies to market
- strategies to accelerate drug development cycles and regulatory pathways
- what the future holds for researchers and the investors eager to capitalize on emerging science
- why GCRIS and its collaborative, unscripted conversations are needed now more than ever

Whether you’re in research, investment, or policy, this episode is essential listening for anyone who wants to stay ahead of the curve in cancer innovation.

Request your invitation to attend the GCRIS taking place October 5-6, 2026 in New York City: https://avbcc.org/gcris/

********************************************
Resources & Links
• Swim Across America: https://www.swimacrossamerica.org

Contact Value-Based Voices

- Follow AVBCC on LinkedIn

- View our podcast lineup

- Contact us at info@avbcc.org

Thanks for listening!

Breaking the Model: Can Value-Based Insurance Deliver?

Saison 1 · Épisode 8

mardi 2 juin 2026 • Durée 32:05

Most cancer drugs today are more effective and accessible than ever—yet patients often face crushing costs because our healthcare system still values profit over patient benefit. What if the key to transforming cancer care affordability lies in rethinking insurance design, reforming PBMs, and empowering employers with transparent data?

In this eye-opening episode of Value-Based Voices, host Jayson Slotnik, JD, MPH, Partner, Health Policy Strategies, Inc., and Member of the AVBCC Board of Directors, sits down with healthcare thought leader John O'Brien, PharmD, MPH, President and CEO of the National Pharmaceutical Council, and healthcare policy strategist Brian Reid, MS, Senior Fellow at Tufts-CEVR and author of the Cost Curve newsletter. They explore how recent policy shifts, advances in medicine, and innovative data tools could finally create a healthcare environment where high-value cancer treatments reach those who need them most—without unnecessary barriers or skyrocketing costs.

Discover the revolutionary potential of value-based insurance design and how new approaches to drug pricing, formulary placement, and patient cost sharing could reshape the future of cancer care. You'll learn about the critical barriers—such as rebates, rebates-driven formulary decisions, and cost-sharing hurdles—and how a data-rich, employer-led movement could finally tip the balance toward affordability and access. We break down the crucial role of employers, PBMs, and policy reforms in enabling this shift, as well as the clinical, economic, and patient-centered benefits of prioritizing value. With insights from recent research, upcoming innovations in cancer medicine delivery, and a forward-looking view of industry trends, you'll understand why this is the moment to watch for change—and be part of it.

Perfect for healthcare professionals, policymakers, advocates, and anyone impacted by cancer treatment costs—this episode offers a compelling look at the potential to dramatically improve how we deliver and pay for life-saving medicines. If you're ready for a future where affordability meets innovation, this conversation is essential listening.

Resources & Links:

- National Pharmaceutical Council

From the Human Genome Project to 48 Hours: The Rapid Evolution of Tumor Biology

Saison 1 · Épisode 7

mardi 19 mai 2026 • Durée 21:59

Most treatments and diagnostics once took years and hundreds of millions of dollars. Today, it costs less than $100,000 to sequence a genome and open the door to tailored cancer therapies that could save lives. But understanding tumor biology is only half the battle. The real challenge lies in interpreting complex genetic data quickly, accurately, and at scale.

In this episode of AVBCC’s Value-Based Voices, James Hamrick, MD, MPH, Chair, Precision Oncology Alliance at Caris Life Sciences, teams up with John Fox, MD, MHA, Senior Medical Director for the Americas, Illumina, to explore how AI-driven bioinformatics is making genomic insights accessible and actionable. They reveal concrete strategies to overcome systemic hurdles such as inconsistent testing, reimbursement issues, and integrating insights into busy clinical workflows, that currently hinder widespread, equitable adoption of precision medicine.

Discover:

How rapid DNA and RNA sequencing is transforming tumor profiling
The critical role of bioinformatics and AI in interpreting complex genomes for real-world use
Why comprehensive multi-omic panels and gene signatures are changing treatments and clinical trials
The systemic, policy, and reimbursement barriers slowing progress, and what can be done to break them down
How timely, precise testing can reduce costs, improve survival, and personalize treatment

This isn’t just about technology, it's about unlocking a new era of value-based, patient-centered cancer care that can save lives and resources.

Resources & Links:

Illumina
National Comprehensive Cancer Network (NCCN)
Caris Life Sciences
Connect with Dr. James Hamrick:
LinkedIn
Connect with Dr. John Fox:
LinkedIn

Podcasts Similaires Basées sur le Contenu

Découvrez des podcasts liées à AVBCC Value-Based Voices . Explorez des podcasts avec des thèmes, sujets, et formats similaires. Ces similarités sont calculées grâce à des données tangibles, pas d'extrapolations !